XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Equity (Deficit)
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2021     359,400,000        
Beginning Balance at Dec. 31, 2021 $ (34) $ (106) $ 10,317 $ 462 $ (8,961) $ (1,924) $ 72
Increase (Decrease) in Shareholders' Equity              
Proceeds from B+L initial public offering, net of costs (Note 2) 675 (190)   (327)   137 865
Common shares issued under share-based compensation plans (in shares)     2,500,000        
Common shares issued under share-based compensation plans 3 3 $ 74 (71)      
Share-based compensation 126 126   126      
Employee withholding taxes related to share-based awards (31) (31)   (31)      
Noncontrolling interest distributions (11)           (11)
Net (loss) income (212) (225)     (225)   13
Other comprehensive (loss) income (256) (269)       (269) 13
Ending Balance (in shares) at Dec. 31, 2022     361,900,000        
Ending Balance at Dec. 31, 2022 260 (692) $ 10,391 159 (9,186) (2,056) 952
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     3,300,000        
Common shares issued under share-based compensation plans     $ 32 (32)      
Share-based compensation 132 132   132      
Employee withholding taxes related to share-based awards (24) (24)   (24)      
Vesting of B+L equity compensation 0 (21)   (21)     21
Noncontrolling interest distributions (9)           (9)
Net (loss) income (611) (592)     (592)   (19)
Other comprehensive (loss) income $ 170 175       175 (5)
Ending Balance (in shares) at Dec. 31, 2023 365,238,917   365,200,000        
Ending Balance at Dec. 31, 2023 $ (82) (1,022) $ 10,423 214 (9,778) (1,881) 940
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     2,600,000        
Common shares issued under share-based compensation plans     $ 67 (67)      
Share-based compensation 150 150   150      
Employee withholding taxes related to share-based awards (26) (26)   (26)      
Vesting of B+L equity compensation 0 (37)   (37)     37
Noncontrolling interest distributions (10)           (10)
Net (loss) income (72) (46)     (46)   (26)
Other comprehensive (loss) income $ (282) (298)       (298) 16
Ending Balance (in shares) at Dec. 31, 2024 367,843,058   367,800,000        
Ending Balance at Dec. 31, 2024 $ (322) $ (1,279) $ 10,490 $ 234 $ (9,824) $ (2,179) $ 957